NCT04415424View on ClinicalTrials.gov

Efficacy Study of 4CMenB (Bexsero®) to Prevent Gonorrhoea Infection in Gay and Bisexual Men

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

650

Participants

Timeline

Start Date

July 8, 2021

Primary Completion Date

June 30, 2025

Study Completion Date

October 30, 2025

Conditions
Neisseria Gonorrheae Infection
Interventions
BIOLOGICAL

4CMenB vaccine

A four-component meningococcal B vaccine

OTHER

Placebo

0.5 ml of 150 mmol sodium chloride (0.9% saline solution)

Trial Locations (7)

2000

Sydney Sexual Health Centre, Sydney

2010

Taylor Square Private Clinic, Sydney

2050

RPA Sexual Health, Sydney

2150

Western Sydney Sexual Health Centre, Parramatta

3053

Melbourne Sexual Health Centre, Carlton

3181

Prahran Market Clinic, Melbourne

4215

Gold Coast Sexual Health Service, Southport

Sponsors

Lead Sponsor

Kirby Institute
All Listed Sponsors
collaborator

Griffith University

OTHER

lead

Kirby Institute

OTHER_GOV